Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $622.07 B |
| Vertex Pharmaceuticals Incorporated | $113.24 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $76.33 B |
| Marinomed Biotech AG | $56.13 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Hofseth BioCare ASA provides value added biomarine ingredients for human, pets, and animal feed markets in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced from salmon bones that enhances bone density and bone deposition in older individuals; and CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome; and a partnership with Catalent Pharma Solutions, Inc. to develop a delayed-release formulation of HBC's OmeGo fish oil. The company was founded in 2000 and is headquartered in à lesund, Norway.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
Hofseth BioCare ASA has the following listings and related stock indices.
Stock: OSE: HBC wb_incandescent
Stock: OSE: HBCO wb_incandescent
Stock: FSX: HBQ wb_incandescent
Stock: OTC: HOFBF wb_incandescent